PPHE Hotel Group Ltd (PPH)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 1,474.00 |
|---|---|
| 52-week range | 1,352.00 – 2,090.00 |
| Return, 1 month / 3 months | −4.5% / −5.5% |
| Return, 1 year / 3 years | +9.6% / +53.6% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 43.8% |
| Worst drawdown (1 year) | -30.3% |
| Average daily value traded | 73.04M GBX |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PPHE Hotel Group is a hotel company that owns, develops and operates hotels in several European countries and the Middle East. Its properties trade under brands such as Park Plaza and art'otel, serving business and leisure guests with rooms, meeting space, restaurants and bars. The group is registered in Guernsey and manages its estate through a combination of ownership, joint ventures and franchise arrangements, alongside a property development arm that builds and repositions hotel real estate.
PPHE Hotel Group Ltd trades under the code PPH on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PPHE Hotel Group Ltd (PPH) trades on the London Exchange in UK. It last closed at GBX 1,474.00 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,330 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.6% and over the last three months it fell 5.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.5% | ||
| From 52-week high | -28.4% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.5% | ||
| 6-month return | -9.7% | ||
| 12-month return, skipping the last month | 14.8% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.3% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 73.04M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | −4.5% |
| 3 months | −5.5% |
| 6 months | −9.7% |
| 1 year | +9.6% |
| 3 years | +53.6% |
| 5 years | +21.7% |
Signals
| 50-day / 200-day average | 1,496.11 / 1,646.47 |
|---|---|
| Golden / death cross (60 days) | Death, 52 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 51.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | GBP 0.1700 |
| 23 Apr 2026 | GBP 0.2200 |
| 18 Sep 2025 | GBP 0.1700 |
| 24 Apr 2025 | GBP 0.2100 |
| 19 Sep 2024 | GBP 0.1700 |
| 25 Apr 2024 | GBP 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.